Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.


The unexpected occurrence of thrombotic microangiopathy (TMA), characterized by microangiopathic hemolytic anemia and thrombocytopenia, in a patient with cancer requires urgent diagnosis and appropriate management. TMA is a term used to describe multiple syndromes caused by microvascular thrombosis, including thrombotic thrombocytopenic purpura (TTP), Shiga… (More)
DOI: 10.1200/JOP.2016.012096

3 Figures and Tables


  • Presentations referencing similar topics